Genitourinary SymptomsNCT00815074
Military Women's Health and Illness Behaviors in Deployed Settings
An observational study of Genitourinary Symptoms, run by 59th Medical Wing at 2 sites in United States.
Trial summary
The purpose of this study is to gain better understanding of how recently deployed military women managed urinary and vaginal symptoms while deployed. Participants in this study will be asked to take part in a 45-60 minute interview. Read more about this study
- Who is it for?
- Ages 18 to 65 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Genitourinary Symptoms
- How many people
- 44 participants
- Where
- 2 sitesUnited States
- Study dates
- 15 Dec 2008to 15 Dec 2011
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Study population: A total of 50 military women.
Who may be able to join
- Deployment within the last 12 months
- Managed genitourinary symptoms while deployed (does not have to be diagnosed by a medical provider)
Who cannot join
- Women who are assigned to a medical group/hospital
Trial locations and contacts
2 sites in 1 country.
United States2 sites
CR Darnall Army Medical Center
Fort Hood, Texas, 76544-4752
Wilford Hall Medical Center
Lackland Air Force Base, Texas, 78236-9908
About this study
The purpose of this study is to gain better understanding of how recently deployed military women managed urinary and vaginal symptoms while deployed. Participants in this study will be asked to take part in a 45-60 minute interview.
- Conditions
- Genitourinary Symptoms
- Being tested
- No intervention
- Keywords
- Military Women, Women's Health, Genitourinary Symptoms, Illness Behaviors, To determine how women manage genitourinary symptoms while deployed.
- Medical subject headings
- Illness Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No interventionOther
no intervention
| Study group | Role | What they receive |
|---|---|---|
| 1 | Women in the military who have returned from deployment within the past 12 months. Receives: Other: No intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Description of deployed experience using qualitative methods
interview data analysis
Measured: 2008 to 2011
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Dec 2008 (estimated)
- Study start15 Dec 2008
- Primary completion15 Dec 2010
- Study completion15 Dec 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Genitourinary SymptomsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 44 participants (actual)
Sponsor and investigators
- Lead sponsor
- 59th Medical Wing
- Sponsor type
- US federal agency
- Responsible party
- Principal investigator, Candy Wilson, 59th Medical Wing
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00815074
- Sponsor's protocol ID
- HU0001-08-1-TS11
- Status last verified
- Jan 2021
- First submitted
- 24 Dec 2008
- Last updated
- 22 Jan 2021
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No: there will be no sharing of the data. The data have been destroyed.
Publications
Wilson C, Corrigan R, Braun L. Deployed women's illness behaviors while managing genitourinary symptoms: An exploratory theoretical synthesis of two qualitative studies. Nurs Outlook. 2017 Sep-Oct;65(5S):S17-S25. doi: 10.1016/j.outlook.2017.07.009. Epub 2017 Jul 15.
PubMed 28800835Wilson C, Nelson JP. Exploring the patterns, practices, and experiences of military women who managed genitourinary symptoms in deployed settings. J Obstet Gynecol Neonatal Nurs. 2012 Mar;41(2):293-302. doi: 10.1111/j.1552-6909.2012.01347.x.
PubMed 22834851
Study at a glance
From the registry record, last updated by the sponsor on 22 Jan 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Military Women's Health and Illness Behaviors in Deployed Settings
- ClinicalTrials.gov ID
- NCT00815074
- Acronym / sponsor ID
- HU0001-08-1-TS11
- Conditions
- Genitourinary Symptoms
- Keywords
- Military Women, Women's Health, Genitourinary Symptoms, Illness Behaviors, To determine how women manage genitourinary symptoms while deployed.
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 44 participants (actual)
- Lead sponsor
- 59th Medical WingUS federal agency
- Study start
- 15 Dec 2008 (actual)
- Primary completion
- 15 Dec 2010 (actual)
- Study completion
- 15 Dec 2011 (actual)
- First posted
- 29 Dec 2008 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to gain better understanding of how recently deployed military women managed urinary and vaginal symptoms while deployed. Participants in this study will be asked to take part in a 45-60 minute interview.
Study design
- Observational model
- Other
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| 1 | – | Other: No interventionWomen in the military who have returned from deployment within the past 12 months. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- A total of 50 military women.
Key inclusion criteria (2 listed)
- Deployment within the last 12 months
- Managed genitourinary symptoms while deployed (does not have to be diagnosed by a medical provider)
Key exclusion criteria (1 listed)
- Women who are assigned to a medical group/hospital
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No interventionno intervention | Other | 1 |
Primary outcome
Description of deployed experience using qualitative methods
Time frame: 2008 to 2011
interview data analysis
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Jan 2021.
- Background: PubMed 28800835Wilson C, Corrigan R, Braun L. Deployed women's illness behaviors while managing genitourinary symptoms: An exploratory theoretical synthesis of two qualitative studies. Nurs Outlook. 2017 Sep-Oct;65(5S):S17-S25. doi: 10.1016/j.outlook.2017.07.009. Epub 2017 Jul 15.
- Results publication: PubMed 22834851Wilson C, Nelson JP. Exploring the patterns, practices, and experiences of military women who managed genitourinary symptoms in deployed settings. J Obstet Gynecol Neonatal Nurs. 2012 Mar;41(2):293-302. doi: 10.1111/j.1552-6909.2012.01347.x.
- Individual participant dataSharing planned: No. there will be no sharing of the data. The data have been destroyed.
Related trials for Genitourinary Symptoms
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Active, not recruitingPhase 2
Safety and Efficacy of Empagliflozin in Hemodialysis
End Stage Renal Disease
RecruitingPhase 3
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
Berger Disease, Bergers Disease
RecruitingPhase 1/2
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
X-linked Hypophosphatemia
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Genitourinary Symptoms, run by 59th Medical Wing at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Description of deployed experience using qualitative methods (time frame: 2008 to 2011). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00815074, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2021.